Skip to main content
Clinical Trials/RBR-3h33wy
RBR-3h33wy
Recruiting
Phase 4

Early empirical antibiotic therapy: a randomized clinical trial for superiority of a ciprofloxacin versus placebo in for preventing secondary bacterial infection among snakebite victims in the Brazilian Amazon

niversidade do Estado do Amazonas0 sitesApril 8, 2016

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Secondary bacterial infection among snakebite victimsSnake venom
Sponsor
niversidade do Estado do Amazonas
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2016
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
niversidade do Estado do Amazonas

Eligibility Criteria

Inclusion Criteria

  • To have less than 24 hours of the accident; did not to use any antibiotics before answering the institution; to have not done the antivenom for the current snakebite ; to have no abscess or infection clearly established at the time of admission ; not to be allergic to the antibiotic of choice in this study ; not to be pregnant and not accept participate.

Exclusion Criteria

  • have mental inability to understand the objectives of the study and participate in the survey; have acute or chronic unstable; unavailability of stay in hospital for seven days to follow.

Outcomes

Primary Outcomes

Not specified

Similar Trials